SICS2022 | Program

Program

June 24 (Fri)

Welcome address

9:00-9:10

Masanori Hatakeyama (The University of Tokyo, Japan)

Keynote Lecture 1

Chair: Yoshinori Murakami (The University of Tokyo)

9:10-10:00

Tatsuhiro Shibata (The University of Tokyo/National Cancer Center, Japan)

Session 1. Genomic evolution

Chair: Atsushi Ochiai (Tokyo Science University / National Cancer Center)

10:00-10:30

Nobuyuki Kakiuchi (Kyoto University, Japan)

Break

10:45-11:15

Chikashi Terao (Riken, Japan)

11:15-11:45

Junko Takita (Kyoto University, Japan)

11:45-12:15

Yukihide Momozawa (Riken, Japan)

Luncheon Seminar 1

Chair: Wataru Obara (Iwate Medical University)
Co-sponsored: MSD K.K.

12:30-13:20

Ryuichi Mizuno (Keio University, Japan)

Keynote Lecture 2

Chair: Atsushi Ochiai (Tokyo Science University / National Cancer Center)

13:30-14:20

Patrick Tan (Duke-National University of Singapore, Singapore)

Poster Session 1

Chair: Tatsuhiro Shibata (The University of Tokyo, National Cancer Center)

14:30-15:30

P1-1	Yoshiaki Usui (RIKEN)
P1-2	Shoichiro Tange (Med. Genome Sci., Inst. Frontier Med., Sappor Med. Univ.)
P1-3	Yasushi Sasaki (Biology Division, Department of Liberal Arts and Sciences, Center for Medical Education, Sapporo Medical University)
P1-4	Keiko Hikino (RIKEN Center for Integrative Medical Sciences)
P1-5	Atsushi Takano (Center for Antibody and Vaccine Therapy, Institute of Medical Science, The University of Tokyo)
P1-6	Masamichi Imajo (Institute for Chemical Reaction Design and Discovery (WPI-ICReDD), Hokkaido University)
P1-7	Serina Tokita (Department of Pathology, Sapporo Medical University)
P1-8	Satoru Matsumoto (Department of Pathology, Sapporo Medical University School of Medicine)
P1-9	Hiroshi Kitajima (Dept. of Molecular Biology, Sapporo Medical Univ.)
P1-10	Naoko Kamiya (Hokkaido University)
P1-11	Rintaro Ohe (Department of Pathology, Yamagata University Faculty of Medicine)

Session 2. Tumor heterogeneity

Chair: Yoshinori Murakami (The University of Tokyo)

15:40-16:10

Alfred Cheng (Chinese University of Hong Kong, China)

16:10-10:40

Toshihiko Torigoe (Sapporo Medical University, Japan)

16:40-17:10

Marco Gerlinger (The Institute of Cancer Research, United Kingdom)

17:10-17:40

Yutaka Suzuki (The University of Tokyo, Japan)

17:40-18:10

Atsushi Ochiai (Tokyo University of Science/National Cancer Center, Japan)

June 25 (Sat)

Session 3. Tumor heterogeneity and plasticity

Chair: Yoshinori Murakami (The University of Tokyo)

9:00-9:30

Trudy Oliver (Duke University, USA)

9:30-10:00

Kyoko Hida (Hokkaido University, Japan)

Session 4. Technological advances

Chair: Yutaka Suzuki (The University of Tokyo)

10:00-10:30

Julia Salzman (Stanford University, USA)

Break

10:45-11:15

Yasuhiro Kojima (Nagoya University, Japan)

11:15-11:45

Yvonne Tay (National University of Singapore, Singapore)

11:45-12:15

Hiroyoshi Nishikawa (National Cancer Center/Nagoya University, Japan)

Luncheon Seminar 2

Chair: Atsushi Mizokami (Kanazawa University Graduate School of Medical Science)
Co-sponsored: Janssen Pharmaceutical K.K.

12:30-13:20

Shusuke Akamatsu (Kyoto University, Japan)

Poster Session 2

Chair: Yoshinori Murakami (The University of Tokyo)

13:30-14:50

P2-1	Jun Suzuka (NEXT-Ganken Prog., JFCR)
P2-2	Takeshi Niinuma (Sapporo Medical University of Medicine)
P2-3	Reo Maruyama (Project for Cancer Epigenomics, Cancer Institute, JFCR)
P2-4	Akira Yorozu (Dept. Otolaryngoly-head and Neck Surgery., Sapporo Med. Univ. Sch. Med.)
P2-5	Yuki Terashima (Sch. of Med. 6th Grade, Hokkaido Univ., Sapporo, Japan)
P2-6	Bayarbat Tsevegjav (Department of Medical Oncology and Cancer Center, Shiga University of Medical Science )
P2-7	Masahiro Matsuki (Hakodate Goryoukaku Hospital)
P2-8	Lei Wang (Institute for Chemical Reaction Design and Discovery Hokkaido University)
P2-9	Shohei Sekiguchi (Department of Oral Surgery., Sapporo Medical University School of Medicine)
P2-10	Ko Okabe (Department of Urology, Sapporo Medical University School of Medicine)
P2-11	Masanori Nojima (The Institute of Medical Science, The University of Tokyo)
P2-12	Radhika Mishra (Laboratory of Biomedical Engineering for Cancer, Graduate School of Biomedical Engineering, Tohoku University)
P2-13	Ariunbuyan Sukhbaatar (Laboratory of Biomedical Engineering for Cancer, Graduate School of Biomedical Engineering, Tohoku University)
P2-14	Regina Mbugua (Dep. Med. Oncol. & Cancer Ctr., Shiga Univ. Med. Sci. Otsu, Shiga, Japan)

Session 5. Clinical impact and drig resistance

Chair: Naoya Masumori (Sapporo Medical University)

15:00-15:30

Koshi Mimori (Kyushu University, Japan)

15:30-16:00

Yoshihisa Kobayashi (National Cancer Center, Japan)

16:00-16:30

Naoya Masumori (Sapporo Medical University, Japan)

16:30-17:00

Yoshinori Murakami (The University of Tokyo, Japan)

Closing remark

17:00-17:10

Yoshinori Murakami (The University of Tokyo, Japan)